Is CDXS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CDXS. It does not provide personalized investment advice.

CDXS (Codexis, Inc.) Stock Analysis - Financials

Codexis, Inc. (CDXS) is a publicly traded Healthcare sector company. As of September 28, 2026, CDXS trades at $1.42 with a market cap of $144.55M and a P/E ratio of -4.01. CDXS moved +7.58% today. Year to date, CDXS is -19.02%; over the trailing twelve months it is -45.00%. Its 52-week range spans $0.96 to $4.51. Analyst consensus is strong buy with an average price target of $6.50. Rallies surfaces CDXS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are CDXS's key financials?

CDXS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CDXS recently traded at $1.42. Market cap is $144.55M. P/E ratio is -4.01. Revenue is $77.68M.

CDXS Key Metrics

Key financial metrics for CDXS
Metric	Value
Price	$1.42
Market Cap	$144.55M
P/E Ratio	-4.01
EPS	$-0.33
Dividend Yield	0.00%
52-Week High	$4.51
52-Week Low	$0.96
Volume	27.15K
Avg Volume	0
Revenue (TTM)	$77.68M
Net Income	$-30.72M
Gross Margin	87.02%

CDXS Analyst Consensus

5 analysts cover CDXS: 0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $6.50.

Common questions about CDXS

What are CDXS's key financials?: CDXS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CDXS recently traded at $1.42. Market cap is $144.55M. P/E ratio is -4.01. Revenue is $77.68M.
Is CDXS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CDXS. It does not provide personalized investment advice.